FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...

FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial ESTERO, FL / / January 7, 2026 / Aspire Biopharma Holdings ...

Acetylsalicylic is readily available in Aspirin tablets. Chemically, it is a useful molecule. It can be converted to salicylic acid and then phenol, which is an extremely useful precursor. Also, the ...

: In this video, I am showing you guys what the "proper" procedure would be, but it is by no means the fastest. If you want ...

For adults with type 2 diabetes, low-dose aspirin (ASA) use is associated with a lower risk for myocardial infarction (MI) and stroke, with greater benefit seen with high-frequency use. HealthDay News ...

Researchers found that the cumulative incidence of MI, stroke, and 10-year all-cause mortality was significantly lower in the ASA group vs the no-ASA group (42.4 vs 61.2%, 14.5 vs 24.8%, and 33 vs ...

A randomised placebo-controlled Finnish study showed that aspirin therapy does not provide significant relief for people suffering from chronic rhinosinusitis with nasal polyps who are hypersensitive ...

Non-steroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD) typically involves hypersensitivity to anti-inflammatory drugs, asthma, and chronic rhinosinusitis with nasal polyps ...

ESTERO, FLORIDA / ACCESS Newswire / September 3, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), developer of a multi-faceted patent-pending drug delivery technology, ...

TxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping of platelets that leads to dangerous blood clots This rapid inhibition is critical during suspected heart attacks, ...